NCT00476151View on ClinicalTrials.gov

A Study of the Efficacy and Safety of Amitriptyline/Ketamine Topical Cream in Patients With Diabetic Peripheral Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

226

Participants

Timeline

Start Date

July 31, 2007

Primary Completion Date

April 30, 2008

Study Completion Date

April 30, 2008

Conditions
Diabetic Peripheral NeuropathyNeuralgia
Interventions
DRUG

EpiCept NP-1 (4% Amitriptyline/ 2% Ketamine) Topical Cream

topical cream applied daily for 4 weeks

DRUG

placebo cream

inactive placebo cream applied two times daily

Trial Locations (1)

Unknown

Multiple Centers, New Delhi

Sponsors
All Listed Sponsors
lead

EpiCept Corporation

INDUSTRY